Attributes | Values |
---|
rdf:type
| |
Description
| - Due to the absence of their neuroprotective potency, both newly developed oximes are not suitable oximes for the antidotal treatment after exposure to soman. The oxime HI-6 is still the best acetylcholinesterase rectivator for the antidotal treatment of acute poisonings with soman.
- Due to the absence of their neuroprotective potency, both newly developed oximes are not suitable oximes for the antidotal treatment after exposure to soman. The oxime HI-6 is still the best acetylcholinesterase rectivator for the antidotal treatment of acute poisonings with soman. (en)
- Z důvodu nedostatečné neuroprotektivní účinnosti nejsou nově vyvinuté oximy vhodnými oximy pro antidotní terapii po expozici somanu. Oxim HI-6 je stále nejlepším reaktivátorem acetylcholinesterázy pro antidotní terapii akutních otrav somanem. (cs)
|
Title
| - Srovnání schopnosti nově vyvinutých oximů (K074, K075) a běžně používaných oximů (obidoxim, HI-6) eliminovat somanem vyvolané projevy neurotoxicity u potkanů (cs)
- A comparison of the potency of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) to counteract soman- induced neurotoxicity in rats
- A comparison of the potency of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) to counteract soman- induced neurotoxicity in rats (en)
|
skos:prefLabel
| - Srovnání schopnosti nově vyvinutých oximů (K074, K075) a běžně používaných oximů (obidoxim, HI-6) eliminovat somanem vyvolané projevy neurotoxicity u potkanů (cs)
- A comparison of the potency of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) to counteract soman- induced neurotoxicity in rats
- A comparison of the potency of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) to counteract soman- induced neurotoxicity in rats (en)
|
skos:notation
| - RIV/60162694:G44__/07:00001750!RIV08-MO0-G44_____
|
http://linked.open.../vavai/riv/strany
| |
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| |
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/60162694:G44__/07:00001750
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - soman; atropine; K oximes; HI-6; obidoxime; functional observational battery (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| - US - Spojené státy americké
|
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| - Drug and Chemical Toxicology
|
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Kassa, Jiří
- Karasová, Jana
|
http://linked.open...n/vavai/riv/zamer
| |
issn
| |
number of pages
| |
http://localhost/t...ganizacniJednotka
| |